Split History
ETFs Holding NVIV »    NVIV Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
InVivo Therapeutics Holdings is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. Co.'s Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The Neuro-Spinal Scaffold implant is intended to provide support to the surrounding tissue after injury, minimize expansion of areas of necrosis, and provide a biomaterial substrate for the body's own healing/repair processes following injury. The Neuro-Spinal Scaffold is composed of poly lactic-co-glycolic acid and Poly-L-Lysine biocompatible and bioresorbable polymers. According to our NVIV split history records, InVivo Therapeutics Holdings has had 3 splits.
NVIV split history picture
InVivo Therapeutics Holdings (NVIV) has 3 splits in our NVIV split history database. The first split for NVIV took place on April 08, 2015. This was a 1 for 4 reverse split, meaning for each 4 shares of NVIV owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 250 share position following the split. NVIV's second split took place on April 17, 2018. This was a 1 for 25 reverse split, meaning for each 25 shares of NVIV owned pre-split, the shareholder now owned 1 share. For example, a 250 share position pre-split, became a 10 share position following the split. NVIV's third split took place on February 12, 2020. This was a 1 for 30 reverse split, meaning for each 30 shares of NVIV owned pre-split, the shareholder now owned 1 share. For example, a 10 share position pre-split, became a 0.333333333333333 share position following the split.

When a company such as InVivo Therapeutics Holdings conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the NVIV split history from start to finish, an original position size of 1000 shares would have turned into 0.333333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into InVivo Therapeutics Holdings shares, starting with a $10,000 purchase of NVIV, presented on a split-history-adjusted basis factoring in the complete NVIV split history. NVIV split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/07/2011
End date: 03/04/2021
Start price/share: $5,550.00
End price/share: $0.91
Dividends collected/share: $0.00
Total return: -99.98%
Average Annual Total Return: -58.17%
Starting investment: $10,000.00
Ending investment: $1.64
Years: 10.00
Date Ratio
04/08/20151 for 4
04/17/20181 for 25
02/12/20201 for 30
NVIV is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

NVLS Split History
NVO Split History
NVUS Split History
NWBO Split History
OBLN Split History
OCLS Split History
OCR Split History
OCRX Split History
OGEN Split History
OGXI Split History

Also explore: NVIV shares outstanding history

Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
MicroSectors FANG+ Index 2X Leveraged ETNs due January 8, 2038 (FNGO)
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038 (FNGU)
Moleculin Biotech, Inc. (MBRX)
Exela Technologies, Inc. (XELA)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

NVIV Insider Buying

NVIV Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.